Merrimack Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
4.00
|
|
Average Rating
|
|
|
# Strong Buys
|
|
|
# Buys
|
|
|
# Holds
|
|
|
# Sells
|
|
|
# Strong Sells
|
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.00
|
-0.03
|
0.00
|
0.00%
|
|
2022-06-30
|
0.00
|
-0.04
|
0.00
|
0.00%
|
|
2022-03-31
|
0.00
|
-0.67
|
0.00
|
0.00%
|
|
2021-12-31
|
0.00
|
-0.67
|
0.00
|
0.00%
|
|
2021-09-30
|
0.00
|
-0.67
|
0.00
|
0.00%
|
|
2021-06-30
|
0.00
|
-0.67
|
0.00
|
0.00%
|
|
2021-03-31
|
0.00
|
-0.67
|
0.00
|
0.00%
|
|
2020-12-31
|
0.00
|
-0.67
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.74
|
|
2021-12-31
|
-2.68
|
|
2020-12-31
|
-1.40
|
|
2019-12-31
|
-2.79
|
|
2018-12-31
|
-3.03
|
|
2017-12-31
|
35.46
|
|
2016-12-31
|
-12.10
|
|
2015-12-31
|
-8.43
|
|
2014-12-31
|
-4.76
|
|
2013-12-31
|
-13.20
|
|
2012-12-31
|
-28.68
|